Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation

被引:335
作者
Zheng, Dan [1 ,2 ]
Giljohann, David A. [1 ,2 ]
Chen, David L. [3 ]
Massich, Matthew D. [1 ,2 ]
Wang, Xiao-Qi [3 ]
Iordanov, Hristo [3 ]
Mirkin, Chad A. [1 ,2 ]
Paller, Amy S. [3 ]
机构
[1] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA
[2] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
transdermal delivery; nanocluster; antisense; nanotechnology; dermatology; MODIFIED GOLD NANOPARTICLES; CELLULAR UPTAKE; IN-VIVO; THERAPY; RNAI; SKIN; INHIBITION; CELLS; DIFFERENTIATION; SUPPRESSION;
D O I
10.1073/pnas.1118425109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Topical application of nucleic acids offers many potential therapeutic advantages for suppressing genes in the skin, and potentially for systemic gene delivery. However, the epidermal barrier typically precludes entry of gene-suppressing therapy unless the barrier is disrupted. We now show that spherical nucleic acid nano-particle conjugates (SNA-NCs), gold cores surrounded by a dense shell of highly oriented, covalently immobilized siRNA, freely penetrate almost 100% of keratinocytes in vitro, mouse skin, and human epidermis within hours after application. Significantly, these structures can be delivered in a commercial moisturizer or phosphate-buffered saline, and do not require barrier disruption or transfection agents, such as liposomes, peptides, or viruses. SNA-NCs targeting epidermal growth factor receptor (EGFR), an important gene for epidermal homeostasis, are >100-fold more potent and suppress longer than siRNA delivered with commercial lipid agents in cultured keratinocytes. Topical delivery of 1.5 uM EGFR siRNA (50 nM SNA-NCs) for 3 wk to hairless mouse skin almost completely abolishes EGFR expression, suppresses downstream ERK phosphorylation, and reduces epidermal thickness by almost 40%. Similarly, EGFR mRNA in human skin equivalents is reduced by 52% after 60 h of treatment with 25 nM EGFR SNA-NCs. Treated skin shows no clinical or histological evidence of toxicity. No cytokine activation in mouse blood or tissue samples is observed, and after 3 wk of topical skin treatment, the SNA structures are virtually undetectable in internal organs. SNA conjugates may be promising agents for personalized, topically delivered gene therapy of cutaneous tumors, skin inflammation, and dominant negative genetic skin disorders.
引用
收藏
页码:11975 / 11980
页数:6
相关论文
共 45 条
[1]   Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[2]   Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs [J].
Aigner, A .
JOURNAL OF BIOTECHNOLOGY, 2006, 124 (01) :12-25
[3]   A combinatorial library of lipid-like materials for delivery of RNAi therapeutics [J].
Akinc, Akin ;
Zumbuehl, Andreas ;
Goldberg, Michael ;
Leshchiner, Elizaveta S. ;
Busini, Valentina ;
Hossain, Naushad ;
Bacallado, Sergio A. ;
Nguyen, David N. ;
Fuller, Jason ;
Alvarez, Rene ;
Borodovsky, Anna ;
Borland, Todd ;
Constien, Rainer ;
de Fougerolles, Antonin ;
Dorkin, J. Robert ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
John, Matthias ;
Koteliansky, Victor ;
Manoharan, Muthiah ;
Nechev, Lubomir ;
Qin, June ;
Racie, Timothy ;
Raitcheva, Denitza ;
Rajeev, Kallanthottathil G. ;
Sah, Dinah W. Y. ;
Soutschek, Juergen ;
Toudjarska, Ivanka ;
Vornlocher, Hans-Peter ;
Zimmermann, Tracy S. ;
Langer, Robert ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :561-569
[4]   Effects of Growth Conditions on the Barrier Properties of a Human Skin Equivalent [J].
Batheja, Priya ;
Song, Yifan ;
Wertz, Philip ;
Michniak-Kohn, Bozena .
PHARMACEUTICAL RESEARCH, 2009, 26 (07) :1689-1700
[5]   The hairless mouse in skin research [J].
Benavides, Fernando ;
Oberyszyn, Tatiana M. ;
VanBuskirk, Anne M. ;
Reeve, Vivienne E. ;
Kusewitt, Donna F. .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 53 (01) :10-18
[6]   Inhibition of HIV fusion with multivalent gold nanoparticles [J].
Bowman, Mary-Catherine ;
Ballard, T. Eric ;
Ackerson, Christopher J. ;
Feldheim, Daniel L. ;
Margolis, David M. ;
Melander, Christian .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (22) :6896-+
[7]   CALCIUM-REGULATED DIFFERENTIATION OF NORMAL HUMAN EPIDERMAL-KERATINOCYTES IN CHEMICALLY DEFINED CLONAL CULTURE AND SERUM-FREE SERIAL CULTURE [J].
BOYCE, ST ;
HAM, RG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 81 (01) :S33-S40
[8]   Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].
Brazma, A ;
Hingamp, P ;
Quackenbush, J ;
Sherlock, G ;
Spellman, P ;
Stoeckert, C ;
Aach, J ;
Ansorge, W ;
Ball, CA ;
Causton, HC ;
Gaasterland, T ;
Glenisson, P ;
Holstege, FCP ;
Kim, IF ;
Markowitz, V ;
Matese, JC ;
Parkinson, H ;
Robinson, A ;
Sarkans, U ;
Schulze-Kremer, S ;
Stewart, J ;
Taylor, R ;
Vilo, J ;
Vingron, M .
NATURE GENETICS, 2001, 29 (04) :365-371
[9]   Spherical Nucleic Acids [J].
Cutler, Joshua I. ;
Auyeung, Evelyn ;
Mirkin, Chad A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (03) :1376-1391
[10]   Polyvalent Nucleic Acid Nanostructures [J].
Cutler, Joshua I. ;
Zhang, Ke ;
Zheng, Dan ;
Auyeung, Evelyn ;
Prigodich, Andrew E. ;
Mirkin, Chad A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (24) :9254-9257